{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:22:07Z","timestamp":1792142527879,"version":"4.4.0"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,7,18]],"date-time":"2002-07-18T00:00:00Z","timestamp":1026950400000},"content-version":"vor","delay-in-days":78,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:p> <jats:bold>Background:<\/jats:bold> CD30\u2010positive cutaneous lymphoproliferative disorders (LPD) represent a spectrum of diseases ranging from low\u2010grade (lymphomatoid papulosis; LyP) to high\u2010grade (pleomorphic and anaplastic large\u2010cell lymphoma; PTL, ALCL) with overlapping morphologic and immunophenotypic features. The common phenotypic hallmark is the expression of CD30\u2010antigen by the tumor cells which morphologically resemble Reed\u2013Sternberg cells. Although LyP is a non\u2010fatal recurring disorder, it is associated with systemic lymphomas including Hodgkin's lymphoma (HL), mycosis fungoides (MF) and ALCL in 5\u201320% of the cases. Currently there is no marker to predict the development of systemic lymphomas in patients with LyP. Fascin, an actin bundling protein, has recently been shown to be a unique marker found in almost 100% of classical HL.<\/jats:p><jats:p> <jats:bold>Methods:<\/jats:bold> Because of the association of LyP with HL, fascin expression was analyzed by immunohistochemistry in LyP (n\u2003=\u200345), cutaneous CD30<jats:sup>+<\/jats:sup> ALCL (n\u2003=\u200317) and pleomorphic T\u2010cell lymphoma (n\u2003=\u20039) (PTL) and LyP associated with systemic lymphomas (7 HL, 2 ALCL, 1 MF), with the intent to determine if fascin expression can predict disease progression.<\/jats:p><jats:p> <jats:bold>Results:<\/jats:bold> Fascin was expressed by tumor cells in 11\/45 (24%) cases of LyP, 11\/17 (64%) cases of ALCL, 7\/9 (77%) cases of PTL and 6\/10 (60%) cases of LyP associated with systemic lymphomas. Fascin expression in LyP was significantly less frequent than in ALCL (p &lt;\u200a0.001) and also than in LyP associated with lymphomas (p &lt;\u200a0.05). There was no significant difference of fascin expression within the histological subtypes of LyP. We found no evidence of ALK expression nor of Epstein\u2013Barr virus expression in any case either by <jats:italic>in situ<\/jats:italic> hybridization or immunohistochemistry in the LyP cases associated with HL.<\/jats:p><jats:p> <jats:bold>Conclusions:<\/jats:bold> This is the first study to demonstrate that fascin is expressed in cutaneous CD30<jats:sup>+<\/jats:sup>\u2003LPD and that it is a candidate marker of disease progression in LyP.<\/jats:p>","DOI":"10.1034\/j.1600-0560.2002.290507.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:55:18Z","timestamp":1047390918000},"page":"295-300","source":"Crossref","is-referenced-by-count":54,"title":["Fascin expression in CD30\u2010positive cutaneous lymphoproliferative disorders"],"prefix":"10.1111","volume":"29","author":[{"given":"Werner","family":"Kempf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edi","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jivko","family":"Kamarashev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Kutzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walther","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Petrogiannis\u2010Haliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall E.","family":"Kadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,7,18]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas. a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze R","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_3_2","first-page":"117","article-title":"Lymphomatoid papulosis and Ki\u20101 (CD30)\u2010positive cutaneous large cell lymphomas","volume":"8","author":"Kaudewitz P","year":"1991","journal-title":"Semin Diagn Pathol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12285562"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis. A continuing self\u2010healing eruption, clinically benign\u2010histologically malignant","volume":"97","author":"Macaulay WL","year":"1968","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930315)71:6<2097::AID-CNCR2820710626>3.0.CO;2-7"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70140-O"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70141-4"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00106.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19921215)70:12<2951::AID-CNCR2820701236>3.0.CO;2-7"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-3-199502010-00009"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261704"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12312548"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12345532"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02459.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.9.5.993"},{"key":"e_1_2_6_17_2","first-page":"543","article-title":"Fascin, a sensitive new marker for Reed\u2013Sternberg cells of Hodgkin's disease","volume":"150","author":"Pinkus GS","year":"1997","journal-title":"Am J Pathol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1128\/jvi.68.11.7320-7328.1994","article-title":"Epstein\u2013Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55\u2010kilodalton actin\u2010bundling protein","volume":"68","author":"Mosialos G","year":"1994","journal-title":"J Virol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/32.2.6198355"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3653"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90943-J"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711700208"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archderm.1996.03890270051007","article-title":"Absence of Epstein\u2013Barr virus in lymphomatoid papulosis. An immunohistochemical and in situ hybridization study","volume":"132","author":"Sangueza OP","year":"1996","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.19352050.x"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0560.2002.290507.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0560.2002.290507.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0560.2002.290507.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T06:43:13Z","timestamp":1697524993000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0560.2002.290507.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1034\/j.1600-0560.2002.290507.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0560.2002.290507.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}